Cargando…

The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation

Extranodal NK/T-cell lymphoma, nasal type (ENKTL), is an aggressive malignancy with a poor prognosis. While the introduction of L-asparaginase in the treatment of this disease has significantly improved the prognosis, the outcome of patients relapsing after asparaginase-based chemotherapy, which occ...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Mel, Sanjay, Soon, Gwyneth Shook-Ting, Mok, Yingting, Chung, Tae-Hoon, Jeyasekharan, Anand D., Chng, Wee-Joo, Ng, Siok-Bian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073933/ https://www.ncbi.nlm.nih.gov/pubmed/29966370 http://dx.doi.org/10.3390/ijms19071931

Ejemplares similares

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma
por: Mustafa, Nurulhuda, et al.
Publicado: (2021)

Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma
por: Zhou, Jianbiao, et al.
Publicado: (2023)

EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma
por: Li, Boheng, et al.
Publicado: (2023)

T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival
por: de Mel, Sanjay, et al.
Publicado: (2022)

Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas
por: Hirpara, Jayshree L., et al.
Publicado: (2016)

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
por: Hee, Yan Ting, et al.
Publicado: (2018)

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
por: Ng, Siok-Bian, et al.
Publicado: (2018)

T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes
por: Oon, Ming Liang, et al.
Publicado: (2021)

MMSET: Role and Therapeutic Opportunities in Multiple Myeloma
por: Xie, Zhigang, et al.
Publicado: (2014)

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
por: Tay, Tricia, et al.
Publicado: (2022)

Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis
por: Chan, Wee-Lee, et al.
Publicado: (2023)

STAT3: A Promising Therapeutic Target in Multiple Myeloma
por: Chong, Phyllis S. Y., et al.
Publicado: (2019)

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2020)

Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS
por: Wai, Cho Mar Myint, et al.
Publicado: (2022)

Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020)

Tumor-Associated Macrophages and Related Myelomonocytic Cells in the Tumor Microenvironment of Multiple Myeloma
por: Wang, Samuel S. Y., et al.
Publicado: (2022)

Implications of Heterogeneity in Multiple Myeloma
por: de Mel, Sanjay, et al.
Publicado: (2014)

Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
por: Kim, Seok Jin, et al.
Publicado: (2013)

Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
por: Hoppe, Michal Marek, et al.
Publicado: (2023)

Potential Clinical Application of Genomics in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2018)

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
por: Selvarajan, V, et al.
Publicado: (2017)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2021)

Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence
por: Abid, Muhammad Bilal, et al.
Publicado: (2016)

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
por: Somasundaram, Nagavalli, et al.
Publicado: (2019)

A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma
por: Chung, Tae-Hoon, et al.
Publicado: (2013)

Recent advances in acute promyelocytic leukaemia
por: Ng, Chin-Hin, et al.
Publicado: (2017)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
por: Soon, Gwyneth, et al.
Publicado: (2021)

Immunoglobulin M Paraproteinaemias
por: Girard, Louis-Pierre, et al.
Publicado: (2020)

Spontaneous regression of locally advanced nonsmall cell lung cancer: A case report
por: Ooi, Kiat Huat, et al.
Publicado: (2018)

Liver lesions detected in a hepatitis B core total antibody-positive patient masquerading as hepatocellular carcinoma: a rare case of peliosis hepatis and a review of the literature
por: Tan, Chun Han Nigel, et al.
Publicado: (2017)

Plasma Cell Neoplasms: Genetics, Pathobiology, and New Therapeutic Strategies
por: Lee, Dong Soon, et al.
Publicado: (2014)

A Rare Case of Primary Bilateral Adrenal Lymphoma
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2017)

Genomic characterization of functional high-risk multiple myeloma patients
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2022)

IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification
por: Teoh, Phaik Ju, et al.
Publicado: (2020)

Treatment outcome of nasal natural killer/T-cell lymphoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)

Macrophages protect mycoplasma‐infected chronic myeloid leukemia cells from natural killer cell killing
por: Choo, Qing Wei Winnie, et al.
Publicado: (2020)

Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
por: Chan, Jason Yongsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ds75fbj54c5s5soitbm8t8v24